#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Behcet's syndrome Arginase deficiency Primary mediastinal large B-cell lymphoma Acquired ATTR amyloidosis Thyroid cancer metastatic Sarcoma Leukodystrophy Brain injury Dermatomyositis Epidermolysis bullosa Anal cancer Cystic fibrosis gastrointestinal disease Marginal zone lymphoma refractory Cutaneous lupus erythematosus Plasma cell myeloma refractory More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome – Basic Information Cerebral arteriovenous malformation haemorrhagic – Life with Disease Cytokine release syndrome – Basic Information Brain stem glioma – Basic Information Cholangitis sclerosing – Treatment Bronchopulmonary dysplasia – Diagnostics Antithrombin III deficiency – Diagnostics Hepatic angiosarcoma Leiomyosarcoma – Diagnostics CADASIL – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mbf-118 Timothy Grass Pollen Extract Anhydrous Cyclophosphamide Follitropin Alfa Montelukast Sodium Art6043 Valsartan Levothyroxine Sodium Levonorgestrel Anidulafungin Lovo-B Leflunomide Fenfluramine Hydrochloride Damoctocog Alfa Pegol Bi 706321 Gallium (68Ga) Psma-R2 Gindameran Triptorelin Acetate Azithromycin Festuca Rubra Pollen More therapies…

    Learn about Your Condition

    Lymphangioma Psoriasis Bacterial prostatitis Post procedural hypotension Haemolytic uraemic syndrome Myocarditis Marginal zone lymphoma Rectal cancer stage II Milk allergy Non-Hodgkin's lymphoma Systemic sclerosis pulmonary Neurofibrosarcoma Frontotemporal dementia Osteomyelitis Endotracheal intubation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Gornoslaskie Centrum Mwdyczne

Gornoslaskie Centrum Mwdyczne

Ul. Ziolowa 45/47, Katowice, 40-635, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Inebilizumab for Adults with Myasthenia Gravis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Inebilizumab
    France Germany Italy Poland Spain

  • Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

    Not recruiting

    3 1
    Investigated Drugs:
    • Asundexian
    Austria Belgium Bulgaria Czechia Denmark Finland +14

  • Study on Ravulizumab for Protecting Chronic Kidney Disease Patients from Acute Kidney Injury After Heart Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acute kidney injury
    Investigated Drugs:
    • Ravulizumab
    France Germany Greece Italy The Netherlands Poland +2

  • Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    • Milvexian
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on Ganaxolone for Patients with Refractory Status Epilepticus

    Not recruiting

    3 1
    Investigated Diseases:
    • Status epilepticus
    Investigated Drugs:
    • Ganaxolone
    Austria Belgium Croatia Czechia Denmark Finland +8
Previous Page
1 … 3 4 5

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!